Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46

Citigroup analyst Yigal Nochomovitz has initiated coverage on Ascentage Pharma Group (NASDAQ: AAPG) with a Buy rating. The firm has set a price target of $46 for the company's stock.